Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration

[1] Bressler SB(2015)Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment JAMA Ophthalmol 133 589-597

[2] Almukhtar T(2011)Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study Ophthalmology 118 831-839

[3] Bhorade A(2011)Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study Ophthalmology 118 663-671

[4] Bressler NM(2011)Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents Br J Ophthalmol 95 1111-1114

[5] Glassman AR(2015)Sustained elevation of intraocular pressure after intravitreal anti-VEGF agents: what is the evidence? Retina 35 841-858

[6] Huang SS(1999)Neuronal death in glaucoma Prog Retin Eye Res 18 39-57

[7] Jampol LM(1991)Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss Arch Ophthalmol 109 77-83

[8] Kim JE(1989)Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma Am J Ophthalmol 107 453-464

[9] Melia M(1984)Diffuse and localized nerve fiber loss in glaucoma Am J Ophthalmol 98 566-571

[10] Schmidt-Erfurth U(1998)Quantitative detection of glaucomatous damage at the posterior pole by retinal thickness mapping: a pilot study Ophthalmology 10 224-231

[1] Bressler SB(2015)Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment JAMA Ophthalmol 133 589-597

[2] Almukhtar T(2011)Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study Ophthalmology 118 831-839

[3] Bhorade A(2011)Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study Ophthalmology 118 663-671

[4] Bressler NM(2011)Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents Br J Ophthalmol 95 1111-1114

[5] Glassman AR(2015)Sustained elevation of intraocular pressure after intravitreal anti-VEGF agents: what is the evidence? Retina 35 841-858

[6] Huang SS(1999)Neuronal death in glaucoma Prog Retin Eye Res 18 39-57

[7] Jampol LM(1991)Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss Arch Ophthalmol 109 77-83

[8] Kim JE(1989)Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma Am J Ophthalmol 107 453-464

[9] Melia M(1984)Diffuse and localized nerve fiber loss in glaucoma Am J Ophthalmol 98 566-571

[10] Schmidt-Erfurth U(1998)Quantitative detection of glaucomatous damage at the posterior pole by retinal thickness mapping: a pilot study Ophthalmology 10 224-231